Aclaris Therapeutics股价因2a期临床试验积极结果大涨

英为财情
Jul 30, 2025

Investing.com -- Aclaris Therapeutics Inc (NASDAQ:ACRS)股价在宣布其ATI-2138治疗中度至重度特应性皮炎的2a期临床试验取得积极顶线结果后,盘后交易中飙升20%。 这家临床阶段生物制药公司报告称,该试验达到了其目标,展示了良好的耐受性和临床上显著的疾病严重程度改善。研究涉及14名患者,他们接受了ATI-2138的低剂量治疗,这是一种...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10